ERBB2 and breast cancer: Recently, it has been demonstrated that the overexpression of HER2/neu in breast cancer enhances the metastatic potential through the upregulation of CXCR4, providing a link between CXCR4 and HER2/neu in tumor progression and metastasis [86].